变应性鼻炎冲击免疫治疗的临床应用

doi:10.6040/j.issn.1673-3770.0.2017.216

摘要/Abstract

摘要： 变应性鼻炎冲击免疫治疗可短时间内增加变应原疫苗的剂量,快速有效地治疗变应性鼻炎。然而由于对其安全性的担忧,国内外开展此项治疗的并不多。对目前冲击免疫治疗的临床应用文献进行分析,探讨其临床推广应用的可行性和价值。

Abstract: In rush immunotherapy for allergic rhinitis, the dosage of allergen is increased in a short time, and this can enhance the efficacy of the treatment. However, owing to concerns regarding its safety, it has been rarely clinically applied. In this paper, a literature review about the clinical application of rush immunotherapy has been conducted to explore and analyze the feasibility of this treatment.

Key words: Desensitization, immunologic, Rush immunotherapy, Allergens, Allergic rhinitis

中图分类号:

R765.21

朱新华. 变应性鼻炎冲击免疫治疗的临床应用[J]. 山东大学耳鼻喉眼学报, 2017, 31(3): 13-17.

ZHU Xinhua. Clinical applicationof rush immunotherapy for allergic rhinitis.[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 13-17.

参考文献

[1] Yuan Zhang, Luo Zhang. Prevalence of Allergic Rhinitis in China[J].Allergy Asthma Immunol Res, 2014, 6(2):105-113.
[2] Varshney J, Varshney H. Allergic Rhinitis: an Overview[J]. Indian J Otolaryngol Head Neck Surg, 2015, 67(2):143-149.
[3] Lisa M, Wheatley MD, M PH, et al. Allergic rhinitis[J]. N Engl J Med, 2015, 372(5): 456-463.
[4] Jutel M, Agache I, Bonini S, et al. International consensus on allergen immunotherapy II:Mechanisms,standardization,and pharmacoeconomics[J]. J Allergy Clin Immunol, 2016, 137(2):358-368.
[5] Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy[J]. J Allergy Clin Immunol, 2015, 136(3):556-568.
[6] 程雷. 特异性免疫治疗是变应性鼻炎的一线疗法[J]. 山东大学耳鼻喉眼学报, 2016, 30(4):1-2. CHENG Lei. Allergen-specific immunotherapy as the first-line treatment for allergic rhinitis[J]. J Otolaryngol Ophthalmol Shandong Univ, 2016, 30(4):1-2.
[7] Jutel M, Kosowska A, Smolinska S. Allergen immunotherapy: Past, present, and future[J].Allergy Asthma Immunol Res, 2016, 8(3):191-197.
[8] Di Bona D, Plaia A, Leto-Barone MS, et al. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison[J]. J Allergy Clin Immunol, 2012, 130(5):1097-1107.
[9] Tabar AI, Echechipía S, García BE, et al. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoidespteronyssinus[J]. J Allergy Clin Immunol, 2005, 116(1):109-118.
[10] Cox LS. Shooting for a faster approach to the immunotherapy target: will cluster become conventional?[J]. Ann Allergy Asthma Immunol, 2009, 102(3):177-178.
[11] Kim HB, Jin HS, Lee SY,et al. The Effect of Rush Immunotherapy with house dust mite in the production of IL-5 and IFN-γ from the peripheral blood T cells of asthmatic children[J]. J Korean Med Sci, 2009, 24(3):392-397.
[12] Davis LS, Bhutani S, Barnett SR, et al. Early gene expression changes with rush immunotherapy[J]. Clin Mol Allergy, 2011, 9:12.
[13] Durham SR, Nelson H. Allergen immunotherapy: A centenary celebration[J]. World Allergy Organ J, 2011, 4(6):104-106.
[14] 卢川,邱前辉,韩虹. 冲击免疫治疗变应性鼻炎[J]. 国际耳鼻咽喉头颈外科杂志, 2012, 36(4):235-237.
[15] 中国过敏性鼻炎研究协作组. 过敏性鼻炎皮下免疫治疗安全性[J]. 中国耳鼻咽喉头颈外科, 2017,24(1):1-14.
[16] Kim ME, Kim JE, Sung JM, et al. Safety of Accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis[J]. J Korean Med Sci, 2011, 26(9): 1159-1164.
[17] 周斌,陈向阳,鲁子健,等. 快速免疫治疗常年性变应性鼻炎[J].耳鼻咽喉头颈外科,2000, 7(6):333-335. ZHOU Bin, CHEN Xiangyang, LU Zijian, et al. Treatment of perennial allergic rhinitis with rushimmunotherapy[J]. Chin Arch Otolaryngol Head Neck Surg, 2000, 7(6):333-335.
[18] 方润琪,姜明华,谢淑琼,等.过敏性鼻炎及支气管哮喘快速脱敏疗法[J]. 云南医药, 1996, 17(3):199-200.
[19] 张玉华,孙进.快速减敏治疗变应性鼻炎疗效观察[J]. 实用临床医药杂志, 2009, 13(12):151-152.
[20] 邱前辉, 卢川, 陈建军, 等. 变应性鼻炎冲击免疫治疗的安全性研究[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 24(11):776-779.
[21] 谢薇, 张汉钟, 陈剑, 等. 冲击免疫治疗变应性鼻炎的有效性与安全性研究[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(8):641-645. XIE Wei, ZHANG Hanzhong, CHEN Jian, et al. Clinical efficacy and safety of rush immunotherapy in patients with allergic rhinitis[J]. Chin J Otorhinolaryngol Head Neck Surg, 2015, 50(8):641-645.
[22] Bernstein DI, Wanner M, Borish L, et al. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001[J]. J Allergy Clin Immunol, 2004, 113(6):1129-1136.
[23] Toogood JH. CSM Update: Desensitisingvaccines[J]. Br Med J(Clin Res Ed), 1986, 293(6552):948.
[24] Lockey RF, Benedict LM, Turkeltaub PC, et al. Fatalities from immunotherapy(IT)and skin testing(ST)[J]. J Allergy Clin Immunol, 1987, 79(4):660-667.
[25] Reid MJ, Lockey RF, Turkeltaub PC. et al. Survey of fatalities from skin testing and immunotherapy 1985-1989[J]. J Allergy Clin Immunol, 1993, 92(1 pt 1):6-15.
[26] Rezvani M, Bernsterin DI. Anaphylactic reactions during immunotherapy[J]. Immunol Allergy Clin North Am, 2007, 27(2):295-307.
[27] Tanaka Y, Okafuji I, Narabayashi S, et al. Safety and efficacy of one-year rush subcutaneous immunotherapy in Japanese children, using house dust extract[J]. Arerugi, 2015, 64(8):1160-1168.
[28] Nam YH, Lee SK. Physicians recommendation and explanation is important in the initiation and maintenance of allergen immunotherapy[J]. Patient Prefer Adherence, 2017, 11: 381-387.
[29] Brehler R, Klimek L, Pfaar O, et al. Safety of a rush immunotherapy build-up schedule with depigmented polymerized allergen extracts[J]. Allergy Asthma Proc, 2010, 31(3):e31-38.
[30] Cox L. Advantages and disadvantages of accelerated immunotherapy schedules[J]. J Allergy Clin Immunol, 2008, 122(2): 432-434.
[31] Bachert C, VanCauwenbeerge P. The WHO ARIA(allergic rhinitis and its impact on asthma)initiative[J]. Chem Immunol Allergy, 2003, 82(3):119-126.
[32] Nagao M, Hiraguchi Y, Hosoki K, et al. Allergen- induced Basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis[J]. Int Arch Allergy Immunol, 2008, 146(suppl 1):47-53.
[33] Smits W, Inglefield JT, Letz K, et al. Improved immunotherapy with a rapid allergen vaccination schedule: a study of 137 patients[J]. Ear Nose Throat J, 2003, 82(11):881-887.
[34] Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy[J]. N Engl J Med, 1999, 341(7):468-475.
[35] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎诊断和治疗指南[J]. 中华耳鼻咽喉头颈外科杂志, 2016, 51(1):6-24. Subspecialty Group of Rhinology, Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery; Subspecialty Group of Rhinology, Society of Otorhinolaryngology Head and Neck Surgery, Chinese Medical Association. Chinese guidelines for diagnosis and treatment of allergic rhinitis[J]. Chin J Otorhinolaryngol Head Neck Surg, 2016, 51(1):6-24.
[36] Kowalski ML, Ansotegui I, Aberer W, et al. Risk and safety requirements for diagnostic and therapeutic procedures in allergology:World Allergy Organization Statement[J]. World Allergy Organ J, 2016, 9(1):33.

相关文章 15

[1]	吕倩,唐源,顾子君,施赛磊,刘萍,万文锦. 变应性鼻炎患者疾病获益感现状及影响因素分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 21-28.
[2]	顾敏,陆美萍. 纳米药物输送系统在变应性鼻炎过敏原免疫治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 106-111.
[3]	秦娜娜,李玉芬,孙雨浩,魏健,李钦. 基于TGF-β1/Smad信号通路探讨白细胞介素13受体α2对变应性鼻炎大鼠鼻黏膜组织重塑的影响[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 71-77.
[4]	熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[5]	许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33.
[6]	刘怡君,谷悦,官大宇,杨玉成,沈暘. 翼管神经切断术在难治性变应性鼻炎中远期临床疗效和安全性[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 42-48.
[7]	张婷,王美兰,高映勤. 白细胞介素35在变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 139-147.
[8]	张竹萍,彭孜灿,肖振龙,李程,喻迪,王兴龙,陈伟,郭蓓. 新型鼻分泌物嗜酸粒细胞阳离子蛋白-髓过氧化物酶试纸在变应性鼻炎中的应用价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 129-134.
[9]	刘畅,杨景朴,高雨,王文佳. 长春地区儿童变应性鼻炎变应原检测结果分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 51-58.
[10]	周荷青,申琪. 中医药治疗变应性鼻炎疗效的生物标志物研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 168-176.
[11]	王曼娴,郑泉,杨亮. 细菌裂解物治疗变应性鼻炎的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 141-145.
[12]	刘畅,方宏艳,刘敩,富东娜,王贺,王晶,杨景朴. 长春地区秋季变应性鼻炎蒿属花粉致敏特征分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 13-19.
[13]	朱朗,刘志奇. 移动医疗提供的真实世界数据在变应性鼻炎治疗方案中的参考[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 135-139.
[14]	张静祎,董湘依,牟亚魁,宋西成. 细胞焦亡在耳鼻咽喉科疾病中的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 140-148.
[15]	张丽净,冯晓星,刘南仙,赵辉明,陈月华. 石墨烯养护鼻罩结合尘螨的皮下特异性免疫治疗在尘螨变应性鼻炎患者中的应用分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 26-32.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed